NURS 1140 Pharm Final Exam EAQs(Questions and
answers) LATEST UPDATE
Which hmedication hclass hcan hbe hused hin hcombination hwith hantimicrobial hagents hto
heradicate ha hHelicobacter hpylori hinfection?
A. hAntacids
B. hProkinetic hagents
C. hProton hpump hinhibitors
D. hGastrointestinal hprostaglandins h- hANS-C. hProton hpump hinhibitors
Which hmedication hmay hcause hbreast hsoreness hand hgynecomastia?
A. hCimetidine h(Tagamet)
B. hMisoprostol h(Cytotec)
C. hLansoprazole h(Prevacid)
D. hMetoclopramide h(Reglan) h- hANS-A. hCimetidine h(Tagamet)
Which hmedication hwhen hgiven hto ha hpatient htaking ha hproton hpump hinhibitor hmay
hcause hnystagmus?
A. hClopidogrel h(Plavix)
B. hPhenytoin h(Dilantin)
C. hSucralfate h(Carafate)
D. hWarfarin h(Coumadin) h- hANS-B. hPhenytoin h(Dilantin)
Which hlaboratory htest hdoes hthe hnurse hreview hbefore ha hpatient htakes ha
hmagnesium-based hOTC hantacid hfor hheartburn?
A. hGastric hpH
B. hElectrolytes
C. hLiver hfunction
D. hRenal hfunction h- hANS-D. hRenal hfunction
Which hmedication hcould hbe hbeneficial hfor hthe htreatment hof hintermittent hheartburn?
A. hMisoprostol
B. hEsomeprazole
C. hMetoclopramide
D. hSucralfate h- hANS-B. hEsomeprazole
Which htype hof hulcer hhas hmisoprostol hbeen hknown hto hreduce?
A. hStress
B. hEsophageal
C. hHelicobacter hpylori
D. hNonsteroidal hantiinflammatory hdrug h(NSAID)-induced h- hANS-D. hNonsteroidal
hantiinflammatory hdrug h(NSAID)-induced
, Which hantiulcer hmedications hact hby hantagonizing hhistamine-2 h(H2) hreceptors?
hSelect hall hthat happly.
A. hNizatidine h(Axid)
B. hFamotidine h(Pepcid)
C. hMisoprostol h(Cytotec)
D. hCimetidine h(Tagamet)
E. hEsomeprazole h(Nexium) h- hANS-A, hB, hD
Which hmedications hreduce hgastric hulcers hby hinhibiting hhydrogen hion hpumps?
hSelect hall hthat happly.
A. hAmoxicillin h(Amoxil)
B. hCimetidine h(Tagamet)
C. hMisoprostol h(Cytotec)
D. hPantoprazole h(Protonix)
E. hDexlansoprazole h(Dexilant) h- hANS-D, hE
Which hclass hof hmedication his hbeneficial hfor hthe htreatment hof hZollinger-Ellison
hsyndrome?
A. hAntacids
B. hCoating hagents
C. hGastrointestinal hprostaglandin
D. hProton hpump hinhibitors h- hANS-D. hProton hpump hinhibitors
Which hdrug hclass hhastens hemptying hof hthe hstomach hwhen hadministered hto ha
hpatient hfor htreatment hof ha hstomach hdisorder?
A. hAntacids
B. hProkinetic hagents
C. hProton hpump hinhibitors
D. hHistamine-2 hantagonists h- hANS-B. hProkinetic hagents
Which hintervention hmay hhelp hdecrease hthe hunpleasant hchalky htaste hassociated
hwith htaking han hantacid htablet?
A. hTake hhalf hthe hdose hof hmedication.
B. hChange hthe hbrand hand hflavor hof hthe hmedication.
C. hTake hthe htablets halong hwith hantacid horal hsolution.
D. hReport hto hthe hhealthcare hprovider himmediately. h- hANS-B. hChange hthe hbrand
hand hflavor hof hthe hmedication.
Which hstatement his htrue hregarding hsucralfate h(Carafate)?
A. hSucralfate h(Carafate) hcan hinduce hdiarrhea has han hadverse heffect
B. hSucralfate h(Carafate) his ha hprokinetic hagent hthat his hused hto htreat hduodenal
hulcers.
C. hSucralfate h(Carafate) htreats hulcers hby hinhibiting hgastric hsecretions hand haltering
hgastric hpH.
answers) LATEST UPDATE
Which hmedication hclass hcan hbe hused hin hcombination hwith hantimicrobial hagents hto
heradicate ha hHelicobacter hpylori hinfection?
A. hAntacids
B. hProkinetic hagents
C. hProton hpump hinhibitors
D. hGastrointestinal hprostaglandins h- hANS-C. hProton hpump hinhibitors
Which hmedication hmay hcause hbreast hsoreness hand hgynecomastia?
A. hCimetidine h(Tagamet)
B. hMisoprostol h(Cytotec)
C. hLansoprazole h(Prevacid)
D. hMetoclopramide h(Reglan) h- hANS-A. hCimetidine h(Tagamet)
Which hmedication hwhen hgiven hto ha hpatient htaking ha hproton hpump hinhibitor hmay
hcause hnystagmus?
A. hClopidogrel h(Plavix)
B. hPhenytoin h(Dilantin)
C. hSucralfate h(Carafate)
D. hWarfarin h(Coumadin) h- hANS-B. hPhenytoin h(Dilantin)
Which hlaboratory htest hdoes hthe hnurse hreview hbefore ha hpatient htakes ha
hmagnesium-based hOTC hantacid hfor hheartburn?
A. hGastric hpH
B. hElectrolytes
C. hLiver hfunction
D. hRenal hfunction h- hANS-D. hRenal hfunction
Which hmedication hcould hbe hbeneficial hfor hthe htreatment hof hintermittent hheartburn?
A. hMisoprostol
B. hEsomeprazole
C. hMetoclopramide
D. hSucralfate h- hANS-B. hEsomeprazole
Which htype hof hulcer hhas hmisoprostol hbeen hknown hto hreduce?
A. hStress
B. hEsophageal
C. hHelicobacter hpylori
D. hNonsteroidal hantiinflammatory hdrug h(NSAID)-induced h- hANS-D. hNonsteroidal
hantiinflammatory hdrug h(NSAID)-induced
, Which hantiulcer hmedications hact hby hantagonizing hhistamine-2 h(H2) hreceptors?
hSelect hall hthat happly.
A. hNizatidine h(Axid)
B. hFamotidine h(Pepcid)
C. hMisoprostol h(Cytotec)
D. hCimetidine h(Tagamet)
E. hEsomeprazole h(Nexium) h- hANS-A, hB, hD
Which hmedications hreduce hgastric hulcers hby hinhibiting hhydrogen hion hpumps?
hSelect hall hthat happly.
A. hAmoxicillin h(Amoxil)
B. hCimetidine h(Tagamet)
C. hMisoprostol h(Cytotec)
D. hPantoprazole h(Protonix)
E. hDexlansoprazole h(Dexilant) h- hANS-D, hE
Which hclass hof hmedication his hbeneficial hfor hthe htreatment hof hZollinger-Ellison
hsyndrome?
A. hAntacids
B. hCoating hagents
C. hGastrointestinal hprostaglandin
D. hProton hpump hinhibitors h- hANS-D. hProton hpump hinhibitors
Which hdrug hclass hhastens hemptying hof hthe hstomach hwhen hadministered hto ha
hpatient hfor htreatment hof ha hstomach hdisorder?
A. hAntacids
B. hProkinetic hagents
C. hProton hpump hinhibitors
D. hHistamine-2 hantagonists h- hANS-B. hProkinetic hagents
Which hintervention hmay hhelp hdecrease hthe hunpleasant hchalky htaste hassociated
hwith htaking han hantacid htablet?
A. hTake hhalf hthe hdose hof hmedication.
B. hChange hthe hbrand hand hflavor hof hthe hmedication.
C. hTake hthe htablets halong hwith hantacid horal hsolution.
D. hReport hto hthe hhealthcare hprovider himmediately. h- hANS-B. hChange hthe hbrand
hand hflavor hof hthe hmedication.
Which hstatement his htrue hregarding hsucralfate h(Carafate)?
A. hSucralfate h(Carafate) hcan hinduce hdiarrhea has han hadverse heffect
B. hSucralfate h(Carafate) his ha hprokinetic hagent hthat his hused hto htreat hduodenal
hulcers.
C. hSucralfate h(Carafate) htreats hulcers hby hinhibiting hgastric hsecretions hand haltering
hgastric hpH.
